First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation

58Citations
Citations of this article
29Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Donor cell leukemia is a rare complication after allogeneic hematopoietic stem cell transplantation. A 12-month-old boy underwent unrelated donor umbilical cord blood transplant (UCBT) for refractory Langerhan's cell histiocytosis. Forty months after transplantation, he developed acute myeloid leukemia. Cytogenetic and molecular analysis confirmed donor cell origin. The Cord Blood Bank (CBB) contacted the donor's family and established that the child, now 7 years old, was healthy. This represents the first reported case of donor cell leukemia following UCBT. This case illustrates that donor cell leukemia is a rare but real event after UCBT as with other stem cell sources and highlights the need for CBBs to maintain linkage data between donors and recipients. © 2005 by The American Society of Hematology.

Cite

CITATION STYLE

APA

Fraser, C. J., Hirsch, B. A., Dayton, V., Creer, M. H., Neglia, J. P., Wagner, J. E., & Baker, K. S. (2005). First report of donor cell-derived acute leukemia as a complication of umbilical cord blood transplantation. Blood, 106(13), 4377–4380. https://doi.org/10.1182/blood-2005-06-2551

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free